Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move

Michael May, PhD, President, CCRM discusses how AI is impacting life sciences, as well as the current state of the Canadian life sciences infrastructure. This includes a robust clinical trials productivity, an educated work force and the a top three for R&D performance in higher education among the G7. AI in life sciences also benefits from a number of Canadian government programs that supports European and Canadian partnerships, as well as country-support for super clusters.